WHO Model List of Essential Medicines (2021)
|
6.2.4. Antileprosy medicines
|
No observations
|
PAHO Strategic Fund Medicine List
|
2.2. Antileprosy med.
|
No observations
|
Peru
|
6.2.3 Anti-Leprosy
|
No observations
|
Ecuador
|
Essential Medicines List - Ecuador
|
No observations
|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.
|
Anti-Infectives Antileprotic
|
Others observations:
Retard
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
02. Antibióticos
|
No observations
|
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.
|
CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.
|
Others observations:
X 30 TABLETAS
|
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015
|
07.02 ANTILEPROTIC DRUGS
|
No observations
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS
|
No observations
|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020
|
J. ANTI-INFECCIOSOS PARA USO SISTEMICO
|
No observations
|
Paraguay. Lista de Medicamentos Esenciales. 2009
|
04. ANTIMICOBACTERIAS (TUBERCULOSIS Y LEPRA)
|
No observations
|
El Salvador - 2019
|
ANTIMICOBACTERIANOS
|
No observations
|
Chile. Formulario Nacional de Medicamentos. 2005
|
06.02. ANTIBACTERIANOS
|
No observations
|
Guyana. Essential Medicines List. 2020-2021
|
7.03. Antileprosy Medicines
|
No observations
|
Guyana. Essential Medicines List. 2020-2021
|
7.09.02.04. Anti-pneumocystosis and antitoxoplasmosis Medicines
|
No observations
|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021
|
8:38 Anti-leprotic agents
|
No observations
|
Suriname. NGK-C-011
|
6.05 Anti-Leprosy drugs
|
No observations
|
Haiti. National List of Essential Medicines
|
06.02.03 Antileprosy
|
No observations
|
Barbados. Barbados National Drug Formulary (BNDF)
|
08.16.92 Miscellaneous Antimycobacterials
|
No observations
|
Bahamas. Drug Formulary
|
07.01.04. Antileprotics
|
No observations
|